Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Obstetrics DepartmentUNIFESP, EPM, Obstetrics DepartmentSciEL
BACKGROUND: Administration of magnesium sulphate (MgSO4) to women with imminent preterm birth at <34...
Background: Evidence supports magnesium sulphate (MgSO4) for women at risk of immin...
BACKGROUND Magnesium sulphate is extensively used in obstetrics for the treatment and prevention of ...
ResumenIntroducciónEl empleo de sulfato de magnesio para neuroprotección fetal es un tratamiento cad...
RESUMENLa prevención del parto prematuro es uno de los desafíos de la obstetricia en el siglo XXI. L...
OBJECTIVE: To provide guidelines for the use of antenatal magnesium sulphate (MgSO4) for fetal neuro...
Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy f...
Background: Preterm birth is the major cause of perinatal mortality both in developed and developing...
International audienceBACKGROUND: Magnesium sulphate (MgSO4) is the only treatment approved for feta...
Premature birth is the main risk factor for cerebral palsy. The strategy used to reduce the rate of ...
BACKGROUND: The prevalence of preterm labour is increasing , while survival of infants born preterm...
Despite improvements in perinatal care, preterm birth still occurs regularly and the associated brai...
Background: Preterm birth is increasing each year. These children have more adverse outcomes due to ...
The aim of study is to demonstrate the clinical profile of patients requiring MgSO4 for neuroprotect...
To evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women w...
BACKGROUND: Administration of magnesium sulphate (MgSO4) to women with imminent preterm birth at <34...
Background: Evidence supports magnesium sulphate (MgSO4) for women at risk of immin...
BACKGROUND Magnesium sulphate is extensively used in obstetrics for the treatment and prevention of ...
ResumenIntroducciónEl empleo de sulfato de magnesio para neuroprotección fetal es un tratamiento cad...
RESUMENLa prevención del parto prematuro es uno de los desafíos de la obstetricia en el siglo XXI. L...
OBJECTIVE: To provide guidelines for the use of antenatal magnesium sulphate (MgSO4) for fetal neuro...
Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy f...
Background: Preterm birth is the major cause of perinatal mortality both in developed and developing...
International audienceBACKGROUND: Magnesium sulphate (MgSO4) is the only treatment approved for feta...
Premature birth is the main risk factor for cerebral palsy. The strategy used to reduce the rate of ...
BACKGROUND: The prevalence of preterm labour is increasing , while survival of infants born preterm...
Despite improvements in perinatal care, preterm birth still occurs regularly and the associated brai...
Background: Preterm birth is increasing each year. These children have more adverse outcomes due to ...
The aim of study is to demonstrate the clinical profile of patients requiring MgSO4 for neuroprotect...
To evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women w...
BACKGROUND: Administration of magnesium sulphate (MgSO4) to women with imminent preterm birth at <34...
Background: Evidence supports magnesium sulphate (MgSO4) for women at risk of immin...
BACKGROUND Magnesium sulphate is extensively used in obstetrics for the treatment and prevention of ...
DOI
Add to ORKG